Asmalin (Salbutamol)

Therapeutic Group : Inhaler Asmalin HFA Inhaler: Each puff delivers Salbutamol Sulphate BP equivalent to Salbutamol 100 µg. Indications: Bronchospasm: Asmalin HFA Inhaler is indicated for the treatment or prevention of bronchospasm in bronchial asthma and for the treatment of reversible airways obstruction associated with bronchitis and emphysema. Exercise-Induced Bronchospasm : Asmalin HFA Inhaler may […]

Arulina-500 (Spirulina)

Therapeutic Group : Herbal Arulina-500 Capsule: Each capsule contains Spirulina 500 mg. Pharmacology: Spirulina is a blue-green algae that provides comprehensive, high-quality nutrition. With over 100 nutrients, Spirulina is often described as the most complete food source in the world. Spirulina contains vegetable protein (60-70%, 3-4 times higher than fish or beef), multivitamins (Vitamin A, […]

Arthanib XR (Tofacitinib)

Therapeutic Group : Antirheumatic Pharmacology: Tofacitinib is an oral Janus kinase (JAK) inhibitor for the treatment of rheumatoidarthritis and psoriatic arthritis. Tofacitinib inhibits JAK dependent cytokinesignaling. JAKs are intracellular enzymes which transmit signals arising fromcytokine or growth factor-receptor interactions on the cellular membrane. JAKsphosphorylate and activate Signal Transducers and Activators of Transcription(STATs) which modulate intracellular […]

Arthanib (Tofacitinib)

Therapeutic Group : Antirheumatic Pharmacology: Tofacitinib is an oral Janus kinase (JAK) inhibitor for the treatment of rheumatoidarthritis and psoriatic arthritis. Tofacitinib inhibits JAK dependent cytokinesignaling. JAKs are intracellular enzymes which transmit signals arising fromcytokine or growth factor-receptor interactions on the cellular membrane. JAKsphosphorylate and activate Signal Transducers and Activators of Transcription(STATs) which modulate intracellular […]

Arovital (Multivitamin)

Therapeutic Group : Vitamins & Minerals Presentation: Arovital IV Injection: Each vial contains Vitamin B1 (as Thiamine Nitrate BP) 2.5 mg, Vitamin B2 (as Riboflavin Sodium Phosphate BP) 3.6 mg, Nicotinamide BP 40 mg, Vitamin B6 (as Pyridoxine Hydrochloride BP) 4 mg, Pantothenic Acid (as Calcium Pantothenate BP) 15 mg, Vitamin C (as Sodium Ascorbate […]

Arotrix (Permethrin)

Therapeutic Group : Antiscabies Presentation: Arotrix Cream: Each gram cream contains Permethrin INN 50 mg. Indications: Arotrix Cream is indicated for the treatment of scabies and lice infestations. Dosage & Administration: Precise recommendations for administration of Arotrix Cream are not possible because of variation in body surface and skin type from patient to patient. However […]

Arotril (Clonazepam)

Therapeutic Group : Antipsychotic, Neurotonic & Sedative Presentation: Arotril 0.5 mg Tablet: Each tablet contains Clonazepam USP 0.5 mg.Arotril 1 mg Tablet: Each tablet contains Clonazepam USP 1 mg.Arotril 2 mg Tablet: Each tablet contains Clonazepam USP 2 mg. Indications: 1. Epilepsy: Status epilepticus, Lennox-Gastaut syndrome, Infantile spasms, Absences seizure, Myoclonic seizures, Tonic – clonic […]

Aropen (Meropenem )

Therapeutic Group : Antibiotic Presentation: Aropen 500 mg IV Injection/Infusion: Each vial contains sterile powder of Meropenem Trihydrate USP equivalent to Meropenem 500 mg premixed with Sodium Carbonate. Aropen 1 g IV Injection/Infusion: Each vial contains sterile powder of Meropenem Trihydrate USP equivalent to Meropenem 1 g premixed with Sodium Carbonate. Indications: Meropenem IV Injection/Infusion […]

Aromatin (Anastrozole)

Therapeutic Group : Aromatase Inhibitor Presentation: Aromatin 1 mg Tablet: Each film coated tablet contains Anastrozole USP 1 mg. Indications: Adjuvant treatment: Aromatin is indicated for adjuvant treatment of postmenopausal women with hormone receptor positive early breast cancer.First line treatment: Aromatin is indicated for the first-line treatment of postmenopausal women with hormone receptor positive or […]

Aroflo (Salmeterol & Fluticasone Propionate)

Therapeutic Group : Inhaler Indications: Aroflo HFA inhaler is indicated in the regular treatment of asthma where use of a combination product (long-acting ß2-agonist and inhaled corticosteroid) is appropriate: 1. patients not adequately controlled with inhaled corticosteroids and ‘as needed’ inhaled short acting ß2-agonist or 2. patients already adequately controlled on both inhaled corticosteroid and […]